Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Ames

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Invasion & Metastasis|January 1, 1992
Antimetastatic activity of boro-amino acid analog protease inhibitors against B16BL6 melanoma in vivoD H Kinder, C A Elstad, G G Meadows, et al.
Cancer Research|March 1, 1979
Phase 1 trial and assay of rubidazone (NSC 164011) in patients with advanced solid tumorsJ S Kovach, M M Ames, M L Sternad, et al.
International Journal of Peptide and Protein Research|May 1, 1996
Peptide boronic acids. Versatile synthetic ligands for affinity chromatography of serine proteinasesD E Zembower, C L Neudauer, M J Wick, et al.
Investigational New Drugs|January 1, 1994
Pyrazine diazohydroxide (NSC-361456). Phase I clinical and pharmacokinetic studiesM V Dhodapkar, R L Richardson, J M Reid, et al.
Journal of Chromatography|August 7, 1987
High-performance liquid chromatographic assay for the experimental anticancer agent oxantrazoleS K Frank, D A Mathiesen, L R Whitfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Phase I study of combined 2-chlorodeoxyadenosine and chlorambucil in chronic lymphoid leukemia and low-grade lymphomaA Tefferi, T E Witzig, J M Reid, et al.
Molecular Pharmacology|November 1, 1983
Thiopurine methyltransferase. Aromatic thiol substrates and inhibition by benzoic acid derivativesL C Woodson, M M Ames, C D Selassie, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
Pharmacology of amygdalin (laetrile) in cancer patientsM M Ames, T P Moyer, J S Kovach, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Preclinical pharmacology of the anthrapyrazole analog oxantrazole (NSC-349174, piroxantrone)S K Frank, D A Mathiesen, M Szurszewski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1J M Reid, M J Kuffel, J K Miller, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Invasion & Metastasis|January 1, 1992
Antimetastatic activity of boro-amino acid analog protease inhibitors against B16BL6 melanoma in vivoD H Kinder, C A Elstad, G G Meadows, et al.
Cancer Research|March 1, 1979
Phase 1 trial and assay of rubidazone (NSC 164011) in patients with advanced solid tumorsJ S Kovach, M M Ames, M L Sternad, et al.
International Journal of Peptide and Protein Research|May 1, 1996
Peptide boronic acids. Versatile synthetic ligands for affinity chromatography of serine proteinasesD E Zembower, C L Neudauer, M J Wick, et al.
Investigational New Drugs|January 1, 1994
Pyrazine diazohydroxide (NSC-361456). Phase I clinical and pharmacokinetic studiesM V Dhodapkar, R L Richardson, J M Reid, et al.
Journal of Chromatography|August 7, 1987
High-performance liquid chromatographic assay for the experimental anticancer agent oxantrazoleS K Frank, D A Mathiesen, L R Whitfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Phase I study of combined 2-chlorodeoxyadenosine and chlorambucil in chronic lymphoid leukemia and low-grade lymphomaA Tefferi, T E Witzig, J M Reid, et al.
Molecular Pharmacology|November 1, 1983
Thiopurine methyltransferase. Aromatic thiol substrates and inhibition by benzoic acid derivativesL C Woodson, M M Ames, C D Selassie, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
Pharmacology of amygdalin (laetrile) in cancer patientsM M Ames, T P Moyer, J S Kovach, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Preclinical pharmacology of the anthrapyrazole analog oxantrazole (NSC-349174, piroxantrone)S K Frank, D A Mathiesen, M Szurszewski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1J M Reid, M J Kuffel, J K Miller, et al.
Pageof 9